Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 52.03%129.88K | -44.61%342.83K | -26.98%67.44K | -64.46%84.4K | 4.95%105.56K | -54.69%85.43K | -61.79%618.94K | -77.09%92.36K | -27.16%237.46K | -73.73%100.58K |
| Selling and administrative expenses | 2.78%79.13K | -29.86%310.3K | -37.24%60.24K | -61.09%75.96K | 1,436.20%97.12K | -51.40%76.99K | -43.61%442.37K | -57.19%96K | 2.32%195.23K | -103.68%-7.27K |
| -General and administrative expense | 2.78%79.13K | -29.86%310.3K | -37.24%60.24K | -61.09%75.96K | 1,436.20%97.12K | -51.40%76.99K | -43.61%442.37K | -57.19%96K | 2.32%195.23K | -103.68%-7.27K |
| Other operating expenses | 501.09%50.76K | -81.58%32.53K | 297.86%7.2K | -80.01%8.44K | -92.17%8.44K | -71.97%8.44K | -78.86%176.57K | -102.03%-3.64K | -68.76%42.24K | -41.80%107.85K |
| Operating profit | -52.03%-129.88K | 44.61%-342.83K | 26.98%-67.44K | 64.46%-84.4K | -4.95%-105.56K | 54.69%-85.43K | 61.79%-618.94K | 77.09%-92.36K | 27.16%-237.46K | 73.73%-100.58K |
| Net non-operating interest income (expenses) | 94.38%-587 | 8.89%-47.3K | -16.17%-12.12K | 49.98%-7.01K | 2.69%-17.73K | -12.93%-10.44K | 26.69%-51.91K | 48.67%-10.44K | 31.43%-14.02K | 13.48%-18.22K |
| Non-operating interest income | ---- | --0 | --0 | --0 | --0 | --0 | -19.74%3.11K | -56.24%894 | --0 | --318 |
| Total other finance cost | -94.38%587 | -14.04%47.3K | 7.00%12.12K | -49.98%7.01K | -4.36%17.73K | -6.31%10.44K | -26.33%55.02K | -49.37%11.33K | -31.98%14.02K | -11.97%18.53K |
| Other net income (expenses) | ||||||||||
| Income before tax | -36.09%-130.47K | 41.85%-390.13K | 22.60%-79.56K | 63.65%-91.41K | -3.78%-123.28K | 51.53%-95.87K | 58.03%-670.86K | 75.73%-102.79K | 1.06%-251.48K | 70.59%-118.79K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -36.09%-130.47K | 41.85%-390.13K | 22.60%-79.56K | 63.65%-91.41K | -3.78%-123.28K | 51.53%-95.87K | 58.03%-670.86K | 75.73%-102.79K | 1.06%-251.48K | 70.59%-118.79K |
| Net income continuous operations | -36.09%-130.47K | 41.85%-390.13K | 22.60%-79.56K | 63.65%-91.41K | -3.78%-123.28K | 51.53%-95.87K | 58.03%-670.86K | 75.73%-102.79K | 1.06%-251.48K | 70.59%-118.79K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -36.09%-130.47K | 41.85%-390.13K | 22.60%-79.56K | 63.65%-91.41K | -3.78%-123.28K | 51.53%-95.87K | 58.03%-670.86K | 75.73%-102.79K | 1.06%-251.48K | 70.59%-118.79K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -36.09%-130.47K | 41.85%-390.13K | 22.60%-79.56K | 63.65%-91.41K | -3.78%-123.28K | 51.53%-95.87K | 58.03%-670.86K | 75.73%-102.79K | 1.06%-251.48K | 70.59%-118.79K |
| Diluted earnings per share | 0 | 0 | 0 | 0 | 0 | 0 | 50.00%-0.01 | 0 | 0 | 0 |
| Basic earnings per share | 0 | 0 | 0 | 0 | 0 | 0 | 50.00%-0.01 | 0 | 0 | 0 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.